Recording: Adverse events and toxicity management in the treatment of mPCa patients from an MDT perspective
Organised by the European School of Urology and the EAU Section of Oncological Urology, this recording aims to educate healthcare professionals (HCPs) on managing adverse events and toxicity in metastatic prostate cancer (mPCa) treatment.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | Not approved |
| Duration | Approx. 60 minutes |
The recording will focus on strengthening the HCPs’ understanding of commonly-faced adverse events and their early detection, improving toxicity management strategies through discussion and case studies, and promoting the importance of a multidisciplinary team (MDT) approach for coordinated care.
Recording aims to enhance the ability of HCPs to handle adverse events and toxicity in mPCa treatment, thereby enhancing patient outcomes through collaborative, informed, and patient-centred approaches.
Speakers:
- Dr. A. Pinto (ES)
- Dr. G. Gandaglia (IT)
This recording is brought to you in collaboration with EAU Section of Oncological Urology.
Acknowledgment
This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.